AMPH and lung carcinoma: However, no antibodies typically found in patients with lung cancer and PND [25], including anti-Hu, anti-CV2/CMRP5, anti-amphiphysin, anti-VGCC, anti-SOX1, anti-GABABR and anti-AMPAR, were present in our patients.